content_image/120543.jpg content_image/120544.jpg content_image/120545.jpg
## 16. Supplementary Information to the Consolidated Balance Sheets 

Balances with affiliates at March 31, 2003 and 2004 were as follows: 

<img src='content_image/120543.jpg'>

## 17. Earnings Per Share 

<img src='content_image/120544.jpg'>

## 18. Supplementary Information to the Consolidated Statements of Operations 

Research and development expenses charged to “selling, general and administrative expenses” for the years ended March 31, 2002, 2003 and 2004 were ·349,855 million, ·285,735 million and ·250,910 million ($2,367,075 thousand), respectively. 

“Other income (expenses)—other, net” for the years ended March 31, 2002, 2003 and 2004 consisted of the following: 

<img src='content_image/120545.jpg'>

